SMAD2 and neoplasm: In tumor‐infiltrated CD8+ T cells prepared from LLC1‐bearing mice, the phosphorylation state of SMAD2/3 exhibited significant time‐dependent variation, with higher phosphorylation levels observed at ZT18 (Figure 5A).